Pulmonary fibrosis is an umbrella term to describe a number of conditions associated with damaging and scarring of the lungs. It is a chronic condition leading to shortness of breath, which markedly impairs a patient’s quality of life. What causes the condition is unclear although it is associated with age and patient numbers are rising in the UK. In this seminar, two leading experts will discuss their research in this area of unmet clinical need.
Speakers
Professor Clare Lloyd is Professor of Respiratory Immunology in the National Heart & Lung Institute at Imperial; Head of Respiratory Sciences Division at the NHLI and Vice-Dean of Institutional Affairs in the Faculty of Medicine. Professor Lloyd’s research group is focused on the cellular and molecular mechanisms underlying the regulation and development of airway inflammation, fibrosis and remodelling.
Professor Toby Maher is Professor of Interstitial Lung Disease at the National Heart and Lung Institute and the British Lung Foundation Chair in Respiratory Research. He is also a consultant respiratory physician at the Royal Brompton Hospital, which hosts the largest Interstitial Lung Disease clinic in Europe. Professor Maher’s translational and clinical research programmes focus on markers of disease and clinical studies into new treatments.